Literature DB >> 18172876

Environmental epigenomics in human health and disease.

Dana C Dolinoy1, Randy L Jirtle.   

Abstract

The epigenome consists of the DNA methylation marks and histone modifications involved in controlling gene expression. It is accurately reproduced during mitosis and can be inherited transgenerationally. The innate plasticity of the epigenome also enables it to be reprogrammed by nutritional, chemical, and physical factors. Imprinted genes and metastable epialleles represent two classes of genes that are particularly susceptible to environmental factors because their regulation is tightly linked to epigenetic mechanisms. To fully understand the etiology of the most devastating diseases that plague humans, the full complexity of the human epigenome will ultimately need to be characterized. Moreover, the elucidation of the interaction of the environment with the epigenome should allow for the development of novel epigenetic-based diagnostic, prevention, and therapeutic strategies for human diseases. Herein, we introduce the emerging field of environmental epigenomics, discuss the importance of imprinted genes and metastable epialleles as epigenetically labile genomic targets, and endorse the genome-wide identification of the full suite of epigenetically labile targets in both the mouse and human genomes. Copyright (c) 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2008        PMID: 18172876     DOI: 10.1002/em.20366

Source DB:  PubMed          Journal:  Environ Mol Mutagen        ISSN: 0893-6692            Impact factor:   3.216


  101 in total

1.  Effects of endocrine disruptors on imprinted gene expression in the mouse embryo.

Authors:  Eun-Rim Kang; Khursheed Iqbal; Diana A Tran; Guillermo E Rivas; Purnima Singh; Gerd P Pfeifer; Piroska E Szabó
Journal:  Epigenetics       Date:  2011-07-01       Impact factor: 4.528

2.  Expanding the scope of environmental risk assessment to better include differential vulnerability and susceptibility.

Authors:  Joel Schwartz; David Bellinger; Thomas Glass
Journal:  Am J Public Health       Date:  2011-10-20       Impact factor: 9.308

3.  DNA methylation shows genome-wide association of NFIX, RAPGEF2 and MSRB3 with gestational age at birth.

Authors:  Hwajin Lee; Andrew E Jaffe; Jason I Feinberg; Rakel Tryggvadottir; Shannon Brown; Carolina Montano; Martin J Aryee; Rafael A Irizarry; Julie Herbstman; Frank R Witter; Lynn R Goldman; Andrew P Feinberg; M Daniele Fallin
Journal:  Int J Epidemiol       Date:  2012-02       Impact factor: 7.196

Review 4.  Allele-specific methylation in the human genome: implications for genetic studies of complex disease.

Authors:  Emma L Meaburn; Leonard C Schalkwyk; Jonathan Mill
Journal:  Epigenetics       Date:  2010-10-01       Impact factor: 4.528

Review 5.  Review: Epigenetic regulation of adipocyte differentiation and adipogenesis.

Authors:  Hong-xing Li; Lei Xiao; Cheng Wang; Jia-li Gao; Yong-gong Zhai
Journal:  J Zhejiang Univ Sci B       Date:  2010-10       Impact factor: 3.066

Review 6.  Epigenomics, gestational programming and risk of metabolic syndrome.

Authors:  M Desai; J K Jellyman; M G Ross
Journal:  Int J Obes (Lond)       Date:  2015-02-02       Impact factor: 5.095

7.  A first look at entire human methylomes.

Authors:  Joseph F Costello; Martin Krzywinski; Marco A Marra
Journal:  Nat Biotechnol       Date:  2009-12       Impact factor: 54.908

8.  Investigating Epigenetic Effects of Prenatal Exposure to Toxic Metals in Newborns: Challenges and Benefits.

Authors:  Monica D Nye; Rebecca C Fry; Cathrine Hoyo; Susan K Murphy
Journal:  Med Epigenet       Date:  2014

9.  Aberrant DNA methylation at Igf2-H19 imprinting control region in spermatozoa upon neonatal exposure to bisphenol A and its association with post implantation loss.

Authors:  Tanvi Doshi; Criselle D'souza; Geeta Vanage
Journal:  Mol Biol Rep       Date:  2013-05-08       Impact factor: 2.316

10.  Epigenetic contributions to cancer metastasis.

Authors:  David I Rodenhiser
Journal:  Clin Exp Metastasis       Date:  2008-04-02       Impact factor: 5.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.